FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND...

24
FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific OTC regulatory initiatives James Atkinson Of Counsel Financial Services Team Norton Rose (Asia) LLP April 2013

Transcript of FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND...

Page 1: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

FINANCIAL INSTITUTIONSENERGYINFRASTRUCTURE, MINING AND COMMODITIESTRANSPORTTECHNOLOGY AND INNOVATIONPHARMACEUTICALS AND LIFE SCIENCES

Asia Pacific OTC regulatory initiatives

James AtkinsonOf CounselFinancial Services TeamNorton Rose (Asia) LLPApril 2013

Page 2: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing2

Topics Key issues for Asia Pacific region Regional implementation overview Cross border case study Singapore implementation process

Page 3: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing3

Key issues for Asia Pacific Region Is global model for OTC regulatory reform a good fit with local

markets in Asia Pac regions? E.g. trading mandate Volumes and liquidity small fraction of US and EU markets – are

implementation costs commensurate with risk? Possible tension between interests of local and international

market participants Objectives of local supervisors – mandatory clearing through

domestic CCPs (especially local currency products) or through offshore CCPs?

Does market scale make local CCPs viable and secure? Will local CCPs be IOSCO-compliant to achieve favourable capital

treatment for cleared trades? Risk of netting fragmentation and market segmentation Scope of extra-territorial effect of Dodd Frank/EMIR

Page 4: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing4

Regional implementation overview Japan – Japan Securities Clearing Corporation (JSCC)– Mandatory clearing of JPY IRS by domestic banks already in force

India– Clearing Corporation of India Limited (CCIL)– Mandatory clearing of FX transactions end-2013

Singapore – SGX Asia Clear

Hong Kong– Hong Kong Exchanges and Clearing (HKEx)

Korea– Korea Exchange (KRX)

Australia– Australian Securities Exchange (ASX)

Page 5: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing5

Cross border case study Requirement in Japan for JPY CDS to be cleared with JSCC

cf JPY IRS – option to clear through JSCC or foreign CCP For trades between US and Japanese CPs either JSCC needs to

register as DCO (application filed but no timeline for completion) or CFTC needs to recognise Japanese regulatory framework

Are requirements for DCO registration compatible with needs of local market?

Long process for recognition of foreign CCP under EMIR– 15 July target for ESMA report of regulatory equivalence of Singapore regime– ESMA agrees memorandum of understanding with MAS – SGX submits application for recognition to ESMA

Separate process for reciprocal recognition by MAS of EU regime

Page 6: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing6

Singapore framework - timeline13 February 2012 MAS Consultation Paper on Proposed Regulation of OTC Derivatives MAS Consultation Paper on Transfer of Regulatory Oversight of Commodity Derivatives

from IE to MA

23 May 2012 Consultation Paper (1) on Proposed Amendments to the Securities and Futures Act on

Regulation of OTC Derivatives Response to Consultation on Policy Reforms on Regulation of OTC Derivatives

3 August 2012 Consultation Paper (2) on Proposed Amendments to the Securities and Futures Act on

Regulation of OTC Derivatives Response to Consultation on Policy Reforms on Regulation of OTC Derivatives Part 2

15 November 2012 Securities and Futures (Amendment) Bill passed by Parliament

10 January 2013 Draft of first implementing regulations published with further regulations to follow

Mid-2014?

Implementation of new OTC regime following conclusion of public consultation process

Page 7: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing7

Singapore framework – amended SFA Securities and Futures (Amendment) Act passed 15 Nov 2013 Introduces new regulation for both wholesale and retail derivatives

markets in light of experience during GFC New Part IIA - introduces new regulatory regime for trade

depositories New Part III - extends current regime for clearing facilities to OTC

derivatives New Part VIA - introduces mandatory reporting New Part VIB - introduces mandatory clearing

Page 8: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing8

Singapore framework – amended SFA Transfer of regulation of commodity derivatives from IE Singapore

Board (under Commodity Trading Act) to MAS (under amended SFA)– Feb 2012 Consultation Paper – MAS states “derivatives contracts” will

encompass OTC commodity derivatives (plus credit, equities, FX and rates)     – Feb 2012 Consultation Paper on Transfer – MAS proposes to retain the power

to bring intangible commodities into the ambit of SFA if necessary– Feb 2012 Consultation Paper on Transfer – MAS proposes to exclude

physically settled commodity forward contracts from the scope of regulation under SFA

– No specific wording in SFA but new definition in s.3 SFAA, once regulation made under s.341 SFA

Page 9: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing9

Singapore framework – amended SFA Part IIA – Trade Repositories Under s.6 SFAA new Part IIA is inserted after s.46 SFA Division 1 (ss.46C-46H) - licensing process for trade repositories

(TRs)– Singapore TR may apply for a trade repository license (to become licensed

trade repository) (LTR)– Foreign TR may apply for a foreign trade repository license (to become licensed

foreign trade repository) (LFTR) Division 2 (ss.46I-46ZA) – regulation of LTRs– Outlines general obligations, business rules, matters requiring MAS approval –

further detail in implementing regulations Division 3 (ss.46ZB-46ZI) – regulation of LFTRs Division 4 (ss.46ZJ-46ZL) – general powers of Authority (i.e. MAS)– S. 46ZJ – power to make implementing regulations for purposes of Part IIA

Page 10: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing10

Singapore framework – amended SFA Part III – Clearing Facilities Under s.7 SFAA previous Part III is repealed and new Part III

substituted (after s.46ZL SFA) Division 1 (ss.49-56) – establishment of clearing facilities– Singapore corporation may either apply for approval as approved clearing

house (ACH) or recognition as recognised clearing house (RCH)– Foreign corporation may only apply for recognition as RCH– Two-tier approach: – systemically important Singapore clearing facilities (all CCPs) to be regulated

as ACHs under equally rigorous standards as designated clearing houses under previous regime

– other Singapore clearing facilities and foreign clearing facilities (including CCPs) to be regulated as RCHs

Division 2 (ss.57-74) – regulation of ACHs– Outlines general obligations, business rules, matters requiring MAS approval –

further detail in implementing regulations Division 3 (ss.75-81A) – regulation of RCH

Page 11: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing11

Singapore framework – amended SFA Part III – Clearing Facilities Division 4 (ss.81B-81O) – insolvency– Key provision – for clearing, porting etc. to work proceedings of clearing house

must take precedence over law of insolvency:– s.81C - list of contracts, transactions, proceedings and dispositions that will

survive insolvency– s81L – Singapore court will not enforce order of a foreign court that Singapore

court would be prohibited from making under amended SFA Division 5 (ss.81P-81SB) – general powers of authority– S. 81Q – power to make implementing regulations for purposes of Part III

Page 12: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing12

Singapore framework – amended SFA Part VIA – Reporting of Derivatives Contracts S.125 – the reporting mandate – “Every specified person who is a party to a specified derivatives contract shall,

at such times and in such form or manner as the Authority may prescribe by regulations made under section 129, report to a licensed trade repository or licensed foreign trade repository:– such information on the specified derivatives contract as the Authority may

prescribe by those regulations; and– any amendment, modification, variation or change to the information referred

to in paragraph (a).”

Page 13: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing13

Singapore framework – amended SFA Part VIA – Reporting of Derivatives Contracts Specified derivatives contract – scope of product– To be prescribed by regulations under s.129– Feb 2012 Consultation Paper – MAS states derivatives across all asset classes

eventually to become reportable but priority to be given based on: (1) significance of product/asset class in Singapore OTC markets; (2) significance of Singapore trading of product/asset class in global OTC markets; and (3) international developments in OTC derivatives reporting

– Plan to initially prioritise interest rate derivatives, FX derivatives and oil derivatives but MAS notes in Aug 2012 Response to Feedback Received that requests received for oil derivatives to be excluded from 1st phase – many participants in market are commodity firms unfamiliar with reporting requirements and lacking necessary infrastructure. MAS response that it would provide for transition period and take into account particular factors cited by participants

Page 14: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing14

Singapore framework – amended SFA Part VIA – Reporting of Derivatives Contracts Specified derivatives contract – scope of contract– To be prescribed by regulations under s.129– Feb 2012 Consultation Paper – MAS proposes all contracts subject to reporting

mandate booked or traded in Singapore will be reportable to eligible TR– MAS will obtain data from TRs in collaboration with other regulators on other

relevant trades e.g. SGD denominated trades or trades referencing Singapore entity

– Aug 2012 Response to Feedback Received – MAS notes comments that trades could be reportable twice – in jurisdiction where they are booked and jurisdiction where they are traded – not necessarily a problem (c.f. clearing) – MAS will align reporting obligations with other jurisdictions where applicable

Page 15: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing15

Singapore framework – amended SFA• Part VIA – Reporting of Derivatives Contracts• Specified person – scope of entity

– To be clarified by regulations under s.129 in relation to non-FIs– All FIs (e.g. banks, insurers etc.) will be specified persons– Feb 2012 Consultation Paper – MAS proposes all non-FIs (persons resident or

with presence in Singapore not regulated by MAS) above a certain threshold (to be prescribed) based on asset size will be specified persons

– Aug 2012 Response to Feedback Received – MAS confirmed that trades between FI and non-FI below reporting threshold would be reportable but only by FI

– No exemption for intra-group trades or trades conducted for hedging purposes

Page 16: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing16

Singapore framework – amended SFA Part VIA – Reporting of Derivatives Contracts S.126 - power of authority to obtain information S.127 - alternative reporting arrangements S.128 – compliance with laws and practices of relevant reporting

jurisdiction – Substituted compliance possible where MAS recognises reporting rules of

“relevant reporting jurisdiction” S.129 – power of authority to make regulations

Page 17: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing17

Singapore framework – amended SFA Part VIB – Clearing of Derivatives Contracts S.129C(1) – the clearing mandate– “Every specified person who is a party to a specified derivatives contract shall,

within such times as the Authority may prescribe by regulations made under section 129G, cause the specified derivatives contract to undergo clearing, by a clearing facility operated by an approved clearing house or recognised clearing house as the case may be.”

Page 18: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing18

Singapore framework – amended SFA• Part VIB – Clearing of Derivatives Contracts• Specified derivatives contract – scope of product

– To be prescribed by regulations under s.129G– Feb 2012 Consultation Paper – MAS recognises that not all products will be

suitable for mandatory clearing e.g. if insufficiently standardised or liquid– MAS proposes to adopt both bottom-up (CCP decides which products to clear

and applies for regulatory approval) and top-down (regulator decides which products should be cleared) approaches and apply similar criteria to US and EU

– MAS propose to exempt deliverable FX forwards and swaps (again in line with US and EU) – no proposal to exempt NDFs

Page 19: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing19

Singapore framework – amended SFA• Part VIB – Reporting of Derivatives Contracts• Specified derivatives contract – scope of contract

– To be prescribed by regulations under s.129G– Feb 2012 Consultation Paper – MAS proposes all contracts subject to clearing

mandate where at least one leg of contract is booked in Singapore and either:– Both parties to contract are resident or have Singapore presence and are

subject to clearing mandate (i.e. are specified persons); or– One party to contract is resident or has Singapore presence and is subject to

clearing mandate and other party would have been subject if resident or had Singapore presence

– Proposed anti-avoidance provision may catch trades between parties where neither is resident or has Singapore presence

– Aug 2012 Response to Feedback Received – MAS notes concerns over possible overlapping/conflicting obligations across different jurisdictions for cross border trades and proposes equivalency approach in response. Singapore counterparty entering derivatives contract with foreign counterparty located in jurisdiction MAS considers to have equivalent safeguards deemed to satisfy Singapore clearing mandate if satisfies foreign clearing mandate

Page 20: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing20

Singapore framework – amended SFA• Part VIB – Reporting of Derivatives Contracts• Specified person – scope of entity

– To be clarified by regulations under s.129G in relation to both FIs and non-FIs– All FIs and non-FIs above a certain threshold (to be prescribed) will be specified

persons:– Threshold for FIs calculated based on minimal derivatives exposure in

aggregate and by asset class – Threshold for non-FIs calculated based on: (1) size of total assets; and (2)

size of derivatives exposure in aggregate and by asset class – excluding hedging transactions qualifying for hedging treatment under Singapore Financial Reporting Standards (or other internationally accepted standards)

– Proposed clearing exemptions for public bodies (e.g. central banks and governments) and intra-group trades (but subject to collateralisation requirement)

– Aug 2012 Response to Feedback Received – MAS noted comments that thresholds should be reviewed periodically and highlighted operational challenges in computing exposures. MAS said it would consult further on the proposed clearing thresholds.

Page 21: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing21

Singapore framework – amended SFA Licensing – requirement for “intermediaries” in derivatives market

to hold capital markets services licence set out in Feb 2012 Consultation Paper

Intended to cover non-bank intermediaries dealing in derivatives contracts where underlying is equity, interest rate, FX, credit or commodity

No implementing provisions in SFAA so currently unclear as to:– Scope of “dealing” – Scope of proposed End-user exemption – indicates parties not in business of

market making or providing intermediating function (e.g. clearing or broking trades for client

Regulations awaited in order to clarify position

Page 22: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing22

Singapore implementation Summary of key issues for end users in Singapore– Which derivatives will be included in 1st phase of implementation of clearing

and reporting mandates (i.e. be prescribed as “specified contracts”?)– Where will thresholds be set for determining whether trader is specified person

for purposes of clearing and reporting mandates?– How will anti-avoidance provisions work in practice re contracts not otherwise

caught by clearing mandate?– Will trader fall within or outside scope of regulations applicable to capital

markets intermediaries (requiring non-bank intermediaries dealing in derivatives contracts to hold capital markets services licence under SFA) – end-user exemption for persons involved in markets only as price-takers, not price-makers and not performing intermediating function

Page 23: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.

IE Singapore briefing23

Disclaimer

The purpose of this presentation is to provide information as to developments in the law. It does not contain a full analysis of the law nor does it constitute an opinion of Norton Rose LLP on the points of law discussed.

No individual who is a member, partner, shareholder, director, employee or consultant of, in or to any constituent part of Norton Rose Group (whether or not such individual is described as a “partner”) accepts or assumes responsibility, or has any liability, to any person in respect of this presentation. Any reference to a partner or director is to a member, employee or consultant with equivalent standing and qualifications of, as the case may be, Norton Rose LLP or Norton Rose Australia or Norton Rose Canada LLP or Norton Rose South Africa (incorporated as Deneys Reitz Inc) or of one of their respective affiliates.

Page 24: FINANCIAL INSTITUTIONS ENERGY INFRASTRUCTURE, MINING AND COMMODITIES TRANSPORT TECHNOLOGY AND INNOVATION PHARMACEUTICALS AND LIFE SCIENCES Asia Pacific.